Return to search

Identification and Characterization of Novel Skeletal Stem Cell Populations in Mice and Humans

Treatments for skeletal tissue injuries include surgery and rehabilitation but in adult patients, the healing process is slow and incomplete, and the underlying biological mechanisms are largely unknown. Skeletal tissues contain stem cells responsible for their maintenance and repair, but the identity and location of these stem cells, and what molecular mechanisms regulate their fate decisions remain unclear. To design more effective regenerative therapies for skeletal conditions, understanding the fundamental biology of skeletal stem cells (SSC) in postnatal organisms is required.
Our project aims at identifying and characterizing these SSC populations in postnatal murine and human tissues using lineage tracing techniques, combined with multicolor 3D confocal microscopy and computational image analysis, in vitro assays, and single cell transcriptomics. We hypothesized that the postnatal skeleton contains self-renewing and multipotent Sox9+ SSCs that persist in adulthood.
We showed that the adult mouse skeleton contains Sox9+ cells self-renewing, multipotent skeletal stem cells (SSCs) with osteogenic and chondrogenic potential. They are located adjacent to the growth plates and in periosteum and persist in adulthood. Transcriptome analysis revealed that these cells express other putative SSCs markers, as well as genes involved in skeletal development, stem cell self-renewal, and fate decision. This data provides testable drug targets to pharmacologically manipulate SSCs fate decisions in situ. In addition, we showed that human tissues contain SSCs similar to murine tissues.
This is the first experimental proof of self-renewal in postnatal Sox9+ SSCs in vivo. These findings provide actionable insights for the use of culture-expanded stem cell product for regenerative medicine product or pharmacological targeting of these stem cells in situ. We believe our data will help improve stem-cell based and tissue engineering therapies, increasing success rate of regenerative orthopaedic surgeries while reducing reoccurrence of injuries.

Identiferoai:union.ndltd.org:uottawa.ca/oai:ruor.uottawa.ca:10393/44550
Date23 January 2023
CreatorsFarhat, Stephanie
ContributorsLegault-Coutu, Daniel
PublisherUniversité d'Ottawa / University of Ottawa
Source SetsUniversité d’Ottawa
LanguageEnglish
Detected LanguageEnglish
TypeThesis
Formatapplication/pdf

Page generated in 0.0026 seconds